Revvity Launches Transcribe AI for Enhanced Laboratory Efficiency
Revvity, Inc. (NYSE: RVTY) has announced the launch of an innovative exciting optical character recognition (OCR) service named Revvity Transcribe AI. This revolutionary tool is designed specifically for clinical laboratories, enabling them to convert handwritten text on test request forms into a digital format. The primary aim of this sophisticated solution is to streamline workflows within laboratories, significantly reducing the burden of manual data entry tasks that often consume valuable time and resources.
Why Revvity Transcribe AI is Essential for Laboratories
The introduction of Revvity Transcribe AI comes against the backdrop of an urgent need for laboratories to efficiently and accurately process test request forms. Many of these tasks currently rely on manual efforts that can be sluggish, lead to potential errors, and struggle with talent shortages. Initial data from internal tests suggest that implementing this solution can boost the overall data entry workflow speed by as much as 40 percent, including improved data validation processes.
Transforming Newborn Screening
While this solution is versatile enough to support a variety of laboratory applications, it holds particular significance for newborn screening (NBS) laboratories. Revvity Transcribe AI is fully compatible with the EVOYA™ platform, which serves as Revvity’s dedicated NBS software solution. In public screening labs, where hundreds of handwritten dried blood spot (DBS) test cards are typically processed every day, incorporating Revvity Transcribe AI can allow laboratories to reallocate their data entry resources to more critical tasks, enhancing overall productivity.
Revvity’s Commitment to Technological Advancement
Norm Lord, the vice president of digital products at Revvity, expressed his enthusiasm for the introduction of this technology, stating, “With the new Revvity Transcribe AI solution, labs can swiftly transcribe handwritten information on test request forms such as DBS filter paper cards using advanced AI-supported OCR technology.” This innovative service is designed to ensure that all digitized data is securely managed and integrated into laboratory information management systems for easy review and verification. By automating this previously labor-intensive process, Revvity Transcribe AI frees up lab personnel to focus on other essential tasks that require immediate attention.
Future Engagements and Innovations
Revvity Transcribe AI is set to take center stage at the upcoming APHL Newborn Screening Symposium. This event, scheduled for October 20-24, will provide a vital opportunity to showcase the unique capabilities of the platform and its potential to transform laboratory operations. These advancements stand to enhance the efficiency and quality of clinical testing, ultimately benefiting patient care and outcomes.
About Revvity
At Revvity, tackling the seemingly impossible drives our innovation. We provide cutting-edge health science solutions, leveraging an array of technologies, expertise, and services designed to cover the entire spectrum of healthcare—from discovery, through development, to diagnosis and treatment. Our specialized focus areas include translational multi-omics technologies, imaging, biomarker identification, and overall informatics, to name a few.
In 2023, Revvity reported revenues exceeding $2.7 billion, employing more than 11,000 people across various sectors. Our reach extends globally, serving clients in pharmaceuticals, biotech, diagnostic labs, academia, and government institutions. As part of the prestigious S&P 500 index, we proudly cater to customers in more than 190 countries, illustrating our commitment to health science advancement worldwide.
Frequently Asked Questions
1. What is Revvity Transcribe AI?
Revvity Transcribe AI is a state-of-the-art optical character recognition (OCR) service that converts handwritten text from test request forms into a digital format, streamlining laboratory workflows.
2. How does Revvity Transcribe AI improve laboratory efficiency?
This innovative solution enhances data entry speed by up to 40%, significantly reducing manual labor and errors associated with traditional data entry methods.
3. Which laboratories can benefit most from this technology?
While effective for various applications, Revvity Transcribe AI is particularly valuable for newborn screening laboratories that require speedy processing of handwritten test cards.
4. What platforms does Revvity Transcribe AI integrate with?
Revvity Transcribe AI is designed to be compatible with the EVOYA™ platform, Revvity’s dedicated software solution for newborn screening.
5. Where can I see Revvity Transcribe AI in action?
The platform will be showcased at the APHL Newborn Screening Symposium, providing insights into its capabilities and applications.
